Tosoh

Glycosylation is one of the most common forms of post-translational modification of proteins.

Degradation studies of biotherapeutic proteins are necessary to test their stability.

Antibody therapeutics are enjoying high growth rates, the major areas of therapeutic application being cancer and immune/inflammation-related disorders including arthritis and multiple sclerosis.

Size exclusion chromatography (sec) is the standard method for aggregate and fragment analysis of monoclonal antibodies in biopharmaceutical qc. A new series of silica-based sec columns was engineered to provide shorter analysis time or higher resolution than standard columns for the separation of fragments, monomers and dimers.

Evaluation of strong and weak cation exchange columns and dependance of seperation on mobile phase ph

During the last decades, mAbs have proofed to be a very valuable medication for severe illnesses like auto immune diseases and cancer.

Antibody therapeutics are enjoying high growth rates in the biopharmaceutical market, the major areas of therapeutic application being cancer and immune/inflammation-related disorders including arthritis and multiple sclerosis.

Static light scattering in combination with size exclusion chromatography is a valuable tool for verifying purity of Monoclonal Antibodies (MABS) as such or as a quick check while the downstream processing takes place.

PEGylation, the process by which polyethylene glycol (PEG) chains are attached to protein and peptide drugs is a common practice in the development of biopharmaceuticals to prolong serum half-life and improve pharmacokinetics of a drug.

Glycosylation is one of the most common forms of post-translational modification of eukaryotic proteins. Glycosylated proteins (glycoproteins) make up the majority of human proteins.